News | July 30, 2025
Torrent Pharmaceuticals posts Q1 FY26 consolidated PAT higher at Rs. 548 Cr
Torrent Pharmaceuticals has reported total income of Rs. 3,141 crores during the period ended June 30, 2025
Torrent Pharmaceuticals has reported total income of Rs. 3,141 crores during the period ended June 30, 2025
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
The revenue witnessed a growth of 7.80 per cent on a year-on-year basis at Rs. 2,959 crore
Torrent Pharmaceuticals has reported total income of Rs. 2,842 crores during the period ended December 31, 2024
The acquisition further strengthens Torrent’s existing diabetes care portfolio and its presence in the Oral Anti Diabetic market
Torrent Pharmaceuticals has reported total income of Rs. 2,883 crores during the period ended June 30, 2024
There was no observation related to data integrity reported
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
Torrent Pharmaceuticals has reported total income of Rs. 2625 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
